Kadmon Holdings, Inc.
KDMNDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557142
Kadmon Holdings, Inc. was delisted in 2021; its insiders filed their last Form 4 on Nov 9, 2021; 169 institutions reported holding it in 13F filings for Q3 2021, worth $1.37B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Kadmon Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Kadmon Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kirsch Arthur S | Director | 0 | Nov 9, 2021 | 0 |
| Konidaris Tasos | Director | – | Nov 9, 2021 | 0 |
| Cohen David E | Director | – | Nov 9, 2021 | 0 |
| Waksal Harlan | President, CEO | 0 | Nov 9, 2021 | 0 |
| Bauer Eugene | Director | 0Indirect | Nov 9, 2021 | 0 |
| Ryan John L | EVP, Chief Medical Officer | – | Nov 9, 2021 | 0 |
| Meehan Steven | EVP, Chief Financial Officer | 0 | Nov 9, 2021 | 0 |
| Miller-Rich Nancy | Director | – | Nov 9, 2021 | 0 |
| Flowers Cynthia Louise | Director | 0 | Nov 9, 2021 | 0 |
| Moss Gregory S. | EVP, Gen. Coun. / CCO. | 0 | Nov 9, 2021 | 0 |
| Carver Kyle | SVP, CAO, Controller | 0 | Nov 9, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.